We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$19.3B
AUM Growth
+$1.53B
Cap. Flow
+$473M
Cap. Flow %
2.45%
Top 10 Hldgs %
16.98%
Holding
3,283
New
233
Increased
1,447
Reduced
1,348
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 7.96%
2 Financials 4.93%
3 Healthcare 4.48%
4 Consumer Discretionary 3.58%
5 Consumer Staples 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHC icon
2926
Bausch Health
BHC
$2.32B
$91K ﹤0.01%
14,417
+2,010
+16% +$14K
NNDM
2927
Nano Dimension
NNDM
$343M
$91K ﹤0.01%
39,396
+5,350
+16% +$13K
PRPL icon
2928
Purple Innovation
PRPL
$28.4M
$90K ﹤0.01%
+754
New +$82.5K
SRNE
2929
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$90K ﹤0.01%
101,326
+1,273
+1% +$1.69K
CNK icon
2930
Cinemark Holdings
CNK
$4.32B
$88K ﹤0.01%
10,112
-1,625
-14% -$18.3K
BRW
2931
Saba Capital Income & Opportunities Fund
BRW
$335M
$87K ﹤0.01%
+11,458
New +$89.7K
EHI
2932
Western Asset Global High Income Fund
EHI
$177M
$87K ﹤0.01%
12,777
-2,949
-19% -$20.5K
SGMA
2933
DELISTED
Sigmatron International
SGMA
$87K ﹤0.01%
22,600
HGTY icon
2934
Hagerty
HGTY
$1.3B
$86K ﹤0.01%
10,245
-521
-5% -$4.53K
ARCO icon
2935
Arcos Dorados Holdings
ARCO
$1.66B
$84K ﹤0.01%
10,050
CXH
2936
DELISTED
MFS Investment Grade Municipal Trust
CXH
$83K ﹤0.01%
11,704
-344
-3% -$2.39K
MVIS icon
2937
Microvision
MVIS
$111M
$83K ﹤0.01%
2,365
-387
-14% -$18K
QVCGA
2938
DELISTED
QVC Group Inc Series A
QVCGA
$81K ﹤0.01%
990
+147
+17% +$15K
BCS icon
2939
Barclays
BCS
$94.4B
$80K ﹤0.01%
+10,219
New +$74.5K
BRTX icon
2940
BioRestorative Therapies
BRTX
$5.41M
$77K ﹤0.01%
28,050
+5,050
+22% +$15.7K
PGEN icon
2941
Precigen
PGEN
$2.45B
$74K ﹤0.01%
48,659
-2,545
-5% -$4.38K
DHY
2942
Credit Suisse High Yield Credit Fund
DHY
$239M
$73K ﹤0.01%
41,634
+200
+0.5% +$367
PCF
2943
High Income Securities Fund
PCF
$102M
$73K ﹤0.01%
11,196
BGC icon
2944
BGC Group
BGC
$5.12B
$72K ﹤0.01%
+19,065
New +$75.3K
GPMT
2945
Granite Point Mortgage Trust
GPMT
$58.8M
$72K ﹤0.01%
13,362
-152
-1% -$987
HERZ
2946
Herzfeld Credit Income Fund
HERZ
$32.4M
$71K ﹤0.01%
2,364
-238
-9% -$7.68K
INO icon
2947
Inovio Pharmaceuticals
INO
$79.6M
$71K ﹤0.01%
3,784
+469
+14% +$10.6K
NRO
2948
Neuberger Real Estate Securities Income Fund Inc
NRO
$188M
$70K ﹤0.01%
23,488
PL icon
2949
Planet Labs
PL
$8.73B
$69K ﹤0.01%
15,950
-4,817
-23% -$24.9K
XXII
2950
22nd Century Group
XXII
$1.49M
0

Similar funds

Cambridge Investment Research Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Cambridge Investment Research Advisors held 3,283 positions worth $19.3B, up 8.6% from $17.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors's Q4 2022 filing shows 233 new, 1,447 increased, 1,348 reduced and 182 closed positions. Its largest new stake was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $22.3M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2022 buy was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M.
  • Cambridge Investment Research Advisors added most to iShares 0-3 Month Treasury Bond ETF in Q4 2022, an estimated $66.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2022 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $22.3M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $12.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $19.3B portfolio in Q4 2022.
  • Cambridge Investment Research Advisors opened 233 new positions and closed 182 in Q4 2022.
  • Cambridge Investment Research Advisors's portfolio value rose 8.6% quarter-over-quarter to $19.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.